AGL - agilon health, inc. Stock Price, Fair Value and News

5.19USD+0.21 (+4.22%)Market Closed

Market Summary

USD5.19+0.21

Market Closed

4.22%

AGL Alerts

Big jump in Revenue (Y/Y)

Big fall in earnings (Y/Y)
Losses in recent quarter

AGL Stock Price

View Fullscreen

AGL RSI Chart

AGL Valuation

Market Cap

2.1B

Price/Earnings (Trailing)

-7.5

Price/Sales (Trailing)

0.45

EV/EBITDA

-11.27

Price/Free Cashflow

-13.47

AGL Price/Sales (Trailing)

AGL Profitability

EBT Margin

-4.30%

Return on Equity

-41.35%

Return on Assets

-12.29%

Free Cashflow Yield

-7.42%

AGL Fundamentals

AGL Revenue

Revenue (TTM)

4.8B

Rev. Growth (Yr)

41.21%

Rev. Growth (Qtr)

96.73%

AGL Earnings

Earnings (TTM)

-284.7M

Earnings Growth (Yr)

-137.85%

Earnings Growth (Qtr)

97.37%

Breaking Down AGL Revenue

Last 7 days

4.6%

Last 30 days

0.2%

Last 90 days

-26.8%

Trailing 12 Months

-80.0%

How does AGL drawdown profile look like?

AGL Financial Health

Current Ratio

1.33

Debt/Equity

0.04

Debt/Cashflow

-4.8

AGL Investor Care

Buy Backs (1Y)

0.86%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	4.8B	0	0	0
2023	2.9B	3.3B	3.9B	4.3B
2022	1.8B	1.9B	2.2B	2.4B
2021	1.3B	1.5B	1.7B	1.5B
2020	900.4M	1.0B	1.1B	1.2B
2019	0	0	0	794.4M
2018	0	0	0	474.8M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of agilon health, inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 15, 2024	desai veeral	acquired	-	-	196,189	chief strategy & dev. officer
Apr 15, 2024	gertsch timothy	acquired	-	-	42,041	chief accounting officer
Apr 15, 2024	sell steven	acquired	-	-	252,243	ceo & president
Apr 15, 2024	shaker benjamin	acquired	-	-	196,189	chief markets officer
Apr 15, 2024	venkatachaliah girish	acquired	-	-	112,108	chief technology officer
Apr 14, 2024	bensley timothy	sold (taxes)	-19,691	4.95	-3,978	chief financial officer
Apr 14, 2024	shaker benjamin	sold (taxes)	-27,254	4.95	-5,506	chief markets officer
Apr 14, 2024	venkatachaliah girish	sold (taxes)	-15,127	4.95	-3,056	chief technology officer
Apr 14, 2024	desai veeral	sold (taxes)	-23,844	4.95	-4,817	chief strategy & dev. officer
Apr 14, 2024	sell steven	sold (taxes)	-38,981	4.95	-7,875	ceo & president

Which funds bought or sold AGL recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	NEW YORK STATE COMMON RETIREMENT FUND	reduced	-1.93	-1,286,000	1,171,000	-%
May 07, 2024	SEI INVESTMENTS CO	reduced	-35.1	-390,899	179,977	-%
May 07, 2024	Qsemble Capital Management, LP	sold off	-100	-157,603	-	-%
May 07, 2024	Swiss National Bank	added	0.57	-3,845,390	3,677,080	-%
May 07, 2024	M&T Bank Corp	new	-	100,643	100,643	-%
May 07, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	added	1,270	3,030,150	3,565,580	-%
May 07, 2024	SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	new	-	2,975,200	2,975,200	0.14%
May 07, 2024	Arizona State Retirement System	reduced	-1.29	-555,007	511,906	-%
May 06, 2024	DUALITY ADVISERS, LP	sold off	-100	-191,601	-	-%
May 06, 2024	Quantbot Technologies LP	new	-	861,808	861,808	0.05%

Are Funds Buying or Selling AGL?

Are funds buying AGL calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AGL

No. of Funds

Unveiling agilon health, inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	7.04%	28,576,261	SC 13G
Feb 12, 2024	morgan stanley	10.8%	43,816,286	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Feb 09, 2024	capital world investors	13.6%	55,218,496	SC 13G/A
Feb 08, 2024	cd&r vector holdings, l.p.	24.6%	1e+08	SC 13G/A
Feb 08, 2024	wellington management group llp	10.47%	42,510,030	SC 13G/A
Sep 08, 2023	morgan stanley	10.7%	43,556,373	SC 13G/A
Sep 08, 2023	wellington management group llp	10.14%	41,124,989	SC 13G/A
Mar 10, 2023	capital world investors	10.3%	42,425,420	SC 13G/A
Feb 13, 2023	capital world investors	9.2%	37,918,473	SC 13G/A

Recent SEC filings of agilon health, inc.

View All Filings

Date Filed	Form Type	Document
May 07, 2024	10-Q	Quarterly Report
May 07, 2024	8-K	Current Report
Apr 18, 2024	ARS	ARS
Apr 18, 2024	DEF 14A	DEF 14A
Apr 18, 2024	DEFA14A	DEFA14A
Apr 17, 2024	4	Insider Trading
Apr 17, 2024	4	Insider Trading
Apr 17, 2024	4	Insider Trading
Apr 17, 2024	4	Insider Trading
Apr 17, 2024	4	Insider Trading

Peers (Alternatives to agilon health, inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	463.9B	371.6B	10.35%	2.61%	20.73	1.25	14.64%	11.24%
CI	98.7B	206.0B	-2.97%	32.18%	25.6	0.48	12.55%	-43.95%
HCA	81.0B	66.7B	-5.69%	12.88%	14.81	1.21	9.59%	-4.59%
CVS	68.9B	360.9B	-26.25%	-21.54%	9.41	0.19	9.07%	78.49%
CNC	40.5B	155.5B	3.95%	12.19%	14.8	0.26	6.34%	84.42%
DVA	11.9B	12.3B	1.61%	34.91%	14.61	0.97	5.77%	58.74%
UHS	11.4B	14.7B	-1.27%	18.38%	13.95	0.78	7.99%	19.23%
MID-CAP
CHE	8.6B	2.3B	-8.25%	4.64%	30.5	3.77	5.96%	18.29%
ACHC	6.1B	3.0B	-12.48%	-3.87%	-542.08	2.05	10.92%	-104.06%
AMN	2.3B	3.8B	2.67%	-35.23%	10.84	0.6	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.72%	19.70%	34.78	1.52	21.19%	34.42%
SMALL-CAP
ADUS	1.8B	1.1B	5.80%	29.14%	26.69	1.61	11.45%	30.74%
BKD	1.4B	3.0B	1.30%	77.47%	-7.77	0.44	4.98%	4.88%
BEAT	54.0M	-	-4.65%	-8.89%	-3.69	-	-	-12.94%
AMS	19.4M	21.3M	3.37%	9.25%	36.46	0.91	8.00%	-62.25%

agilon health, inc. News

Latest updates

agilon health, inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2018Q4
Revenue	96.7%	1,604,354,000	815,504,000	1,215,660,000	1,149,052,000	1,136,147,000	369,783,000	694,858,000	670,134,000	653,445,000	150,821,000	458,613,000	498,956,000	413,104,000	321,007,000	312,684,000	293,594,000	291,048,000	-	-
Costs and Expenses	59.1%	1,611,532,000	1,013,101,500	1,264,631,000	1,178,873,000	1,053,895,000	423,848,000	724,376,000	691,186,000	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	1,129,886,000	758,892,000	724,376,000	691,186,000	654,188,000	510,759,000	494,214,000	797,319,000	425,219,000	360,750,000	322,528,000	294,846,000	296,882,000	-	-
S&GA Expenses	-100.0%	-	63,277,000	74,138,000	81,499,000	66,846,000	64,051,000	51,980,000	51,924,000	39,834,000	25,521,000	46,643,000	317,561,000	37,777,000	45,581,500	30,368,000	34,248,000	27,605,000	-	-
EBITDA Margin	4.7%	-0.04	-0.04	-0.01	-0.02	-0.02	-0.03	-0.03	-0.04	-0.20	-0.24	-0.22	-0.22	-	-	-	-	-	-	-
Interest Expenses	-31.9%	1,284,000	1,886,000	1,651,000	1,588,000	1,533,000	1,668,000	1,000,000	945,000	871,000	840,000	867,000	1,498,000	2,941,000	1,953,000	1,953,000	2,080,000	2,149,000	-	-
Income Taxes	-149.8%	-133,000	267,000	1,210,000	1,073,000	-1,759,000	572,000	559,000	580,000	-71,000	179,000	256,000	435,000	16,000	791,000	35,000	39,000	-	-	-
Earnings Before Taxes	101.9%	3,114,000	-162,667,000	-30,273,000	-15,722,000	14,200,000	-40,923,000	-29,944,000	-20,458,000	655,000	-35,625,000	-36,737,000	-296,894,000	-13,720,000	-38,810,000	-12,266,000	-3,406,000	-7,861,000	-	-
EBT Margin	4.6%	-0.04	-0.05	-0.02	-0.02	-0.03	-0.04	-0.04	-0.05	-0.21	-0.25	-0.23	-0.23	-	-	-	-	-	-	-
Net Income	97.4%	-6,064,000	-230,433,000	-31,436,000	-16,749,000	16,022,000	-56,466,000	-30,668,000	-20,649,000	1,230,000	-56,721,000	-35,843,000	-298,845,000	-15,078,000	-24,215,000	-11,827,000	-7,911,000	-16,099,000	-	-
Net Income Margin	2.2%	-0.06	-0.06	-0.02	-0.03	-0.03	-0.04	-0.05	-0.06	-0.22	-0.27	-0.22	-0.23	-	-	-	-	-	-	-
Free Cashflow	21.8%	-50,915,000	-65,098,000	-17,105,000	-25,298,000	-64,528,000	-53,448,000	-786,000	-64,718,000	-27,282,000	-52,297,000	-21,661,000	-39,759,000	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet															(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2019Q4
Assets	33.1%	2,316	1,741	2,278	2,353	2,170	1,697	1,870	1,841	1,855	1,586	1,685	1,702	574	446	403
Current Assets	37.6%	2,037	1,480	1,957	2,045	1,876	1,451	1,634	1,601	1,628	1,367	1,453	1,480	418	294	246
Cash Equivalents	10.2%	119	108	168	191	394	465	564	684	1,022	1,049	1,082	1,109	105	128	139
Net PPE	-0.1%	28.00	28.00	26.00	24.00	22.00	20.00	18.00	16.00	13.00	9.00	6.00	5.00	5.00	6.00	7.00
Goodwill	0%	24.00	24.00	62.00	62.00	62.00	3.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00
Liabilities	50.8%	1,628	1,080	1,406	1,473	1,088	657	785	737	744	495	558	551	563	422	354
Current Liabilities	56.2%	1,527	977	1,301	1,362	973	535	658	605	610	357	423	412	372	267	200
Long Term Debt	-7.7%	30.00	32.00	35.00	36.00	37.00	38.00	40.00	41.00	42.00	43.00	45.00	46.00	99.00	65.00	67.00
LT Debt, Current	20.0%	8.00	6.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	4.00	-	3.00	3.00
LT Debt, Non Current	-100.0%	-	32.00	35.00	36.00	37.00	38.00	40.00	41.00	42.00	43.00	45.00	46.00	99.00	65.00	67.00
Shareholder's Equity	4.0%	688	662	872	879	1,082	1,041	1,085	1,103	1,111	1,092	1,127	1,150	-	-	-
Retained Earnings	-0.5%	-1,332	-1,326	-1,096	-1,064	-1,048	-1,064	-1,007	-977	-956	-957	-900	-865	-566	-551	-491
Additional Paid-In Capital	1.7%	2,021	1,987	1,971	1,947	2,130	2,107	2,095	2,076	2,064	2,046	2,025	2,012	266	264	257
Shares Outstanding	1.1%	411	406	406	405	414	412	411	407	402	373	365	352	-	-	-
Minority Interest	3.7%	-0.79	-0.82	-0.77	-0.72	-0.67	-0.61	-0.53	-0.46	-0.37	-0.30	-0.28	-0.17	-0.07	-	-
Float	-	-	-	-	5,200	-	-	-	4,500	-	-	-	6,600	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2018Q4
Cashflow From Operations	21.9%	-47,776	-61,166	-13,018	-21,204	-60,811	-49,959	2,647	-60,263	-23,233	-48,897	-19,143	-39,291	-40,828	-13,339	-4,367	-9,371	-26,127	-	-
Share Based Compensation	9.0%	16,909	15,515	20,736	19,572	13,672	9,951	7,907	6,553	3,970	4,414	11,960	274,548	1,472	1,837	1,558	2,155	1,071	-	-
Cashflow From Investing	2434.9%	51,438	-2,203	-11,034	20,032	-50,814	-7,970	-130,938	-296,611	-8,869	-2,603	-11,565	-67,264	-9,074	23,274	1,143	-2,670	319	-	-
Cashflow From Financing	166.2%	559	-845	1,410	-202,037	8,339	1,130	9,111	4,309	13,506	10,417	896	1,112,779	30,298	-760	-6,141	4,154	27,368	-	-
Buy Backs	-100.0%	-	1,409	-	201,564	-	-	-	-	-	-	-	-	-	-	6,742	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

AGL Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Revenues	$ 1,604,354	$ 1,054,312
Expenses:
General and administrative (including noncash stock-based compensation expense of $16,909 and $13,585, respectively)	76,422	69,752
Depreciation and amortization	5,844	2,954
Total expenses	1,611,532	1,053,895
Income (loss) from operations	(7,178)	417
Other income (expense):
Income (loss) from equity method investments	5,684	1,376
Other income (expense), net	5,892	7,892
Interest expense	(1,284)	(1,493)
Income (loss) before income taxes	3,114	8,192
Income tax benefit (expense)	133	1,759
Income (loss) from continuing operations	3,247	9,951
Discontinued operations:
Income (loss) before gain (loss) on sales	(518)	6,008
Gain (loss) on sales of assets, net	(8,763)	0
Total discontinued operations	(9,281)	6,008
Net income (loss)	(6,034)	15,959
Noncontrolling interests’ share in (earnings) loss	(30)	63
Net income (loss) attributable to common shares	$ (6,064)	$ 16,022
Net income (loss) per common share, basic and diluted
Continuing operations, basic (in dollars per share)	$ 0.01	$ 0.02
Continuing operations, diluted (in dollars per share)	0.01	0.02
Discontinued operations, basic (in dollars per share)	(0.02)	0.02
Discontinued operations, diluted (in dollars per share)	$ (0.02)	$ 0.02
Weighted average shares outstanding
Basic (in shares)	408,938	413,136
Diluted (in shares)	413,437	426,586
Medical services revenue
Revenues:
Revenues	$ 1,601,195	$ 1,053,119
Expenses:
Expenses	1,443,842	897,572
Other operating revenue
Revenues:
Revenues	3,159	1,193
Expenses:
Expenses	$ 85,424	$ 83,617

AGL Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 111,706	$ 107,570
Restricted cash and equivalents	6,844	6,759
Marketable securities	307,359	380,773
Receivables, net	1,571,143	942,461
Prepaid expenses and other current assets, net	39,757	42,513
Total current assets	2,036,809	1,480,076
Property and equipment, net	27,539	27,576
Intangible assets, net	72,076	63,769
Goodwill	24,133	24,133
Other assets	155,906	145,312
Total assets	2,316,463	1,740,866
Current liabilities:
Medical claims and related payables	1,266,651	737,724
Accounts payable and accrued expenses	252,497	233,182
Current portion of long-term debt	7,500	6,250
Total current liabilities	1,526,648	977,156
Long-term debt, net of current portion	29,834	32,308
Other liabilities	71,495	70,381
Total liabilities	1,627,977	1,079,845
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.01 par value: 2,000,000 shares authorized; 410,843 and 406,387 shares issued and outstanding, respectively	4,108	4,064
Additional paid-in capital	2,020,803	1,986,899
Accumulated deficit	(1,332,890)	(1,326,826)
Accumulated other comprehensive income (loss)	(2,747)	(2,298)
Total agilon health, inc. stockholders' equity (deficit)	689,274	661,839
Noncontrolling interests	(788)	(818)
Total stockholders’ equity (deficit)	688,486	661,021
Total liabilities and stockholders’ equity (deficit)	$ 2,316,463	$ 1,740,866

About agilon health, inc.

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

CEO	Mr. Steven Jackson Sell
WEBSITE	agilonhealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	747

agilon health, inc. Frequently Asked Questions

What is the ticker symbol for agilon health, inc.? What does AGL stand for in stocks?

AGL is the stock ticker symbol of agilon health, inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of agilon health, inc. (AGL)?

As of Wed May 08 2024, market cap of agilon health, inc. is 2.13 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AGL stock?

You can check AGL's fair value in chart for subscribers.

What is the fair value of AGL stock?

You can check AGL's fair value in chart for subscribers. The fair value of agilon health, inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of agilon health, inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AGL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is agilon health, inc. a good stock to buy?

The fair value guage provides a quick view whether AGL is over valued or under valued. Whether agilon health, inc. is cheap or expensive depends on the assumptions which impact agilon health, inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AGL.

What is agilon health, inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, AGL's PE ratio (Price to Earnings) is -7.5 and Price to Sales (PS) ratio is 0.45. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AGL PE ratio will change depending on the future growth rate expectations of investors.